These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35698560)

  • 1. Antileukemic Effect of Zerumbone-Loaded Nanostructured Lipid Carrier in WEHI-3B Cell-Induced Murine Leukemia Model [Retraction].
    Int J Nanomedicine; 2022; 17():2557-2558. PubMed ID: 35698560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model.
    Rahman HS; Rasedee A; How CW; Zeenathul NA; Chartrand MS; Yeap SK; Abdul AB; Tan SW; Othman HH; Ajdari Z; Namvar F; Arulselvan P; Fakurazi S; Mehrbod P; Daneshvar N; Begum H
    Int J Nanomedicine; 2015; 10():1649-66. PubMed ID: 25767386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
    Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
    Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pumpkin Oil-Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats [Retraction].
    Int J Nanomedicine; 2023; 18():2255-2256. PubMed ID: 37143898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers [Retraction].
    Int J Nanomedicine; 2023; 18():1107-1108. PubMed ID: 36883069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Nanostructured Lipid Carriers Integrated into in situ Nasal Gel for Enhancing Brain Delivery of Flibanserin [Retraction].
    Int J Nanomedicine; 2023; 18():2253-2254. PubMed ID: 37143899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene.
    Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC
    Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileukemic Effect of Palladium Nanoparticles Mediated by White Tea (
    Othman H; Rahman H; Mohan S; Aziz S; Marif H; Ford D; Abdulsamad N; Amin K; Abdullah R
    Evid Based Complement Alternat Med; 2020; 2020():8764096. PubMed ID: 32922508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonium Glycyrrhizinate-Loaded Niosomes as a Potential Nanotherapeutic System for Anti-Inflammatory Activity in Murine Models [Retraction].
    Int J Nanomedicine; 2022; 17():3403-3404. PubMed ID: 35945927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway [Retraction].
    Int J Nanomedicine; 2022; 17():3457-3458. PubMed ID: 35959280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
    Smith C; Muench MO; Knizewski M; Gilboa E; Moore MA
    Leukemia; 1993 Feb; 7(2):310-7. PubMed ID: 8426483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1992 May; 52(10):2782-90. PubMed ID: 1316227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors.
    García-Castro J; Segovia JC; García-Sánchez F; Lillo R; Gómez-Navarro J; Curiel DT; Bueren JA
    Mol Ther; 2001 Jan; 3(1):70-7. PubMed ID: 11162313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clonal response of murine myelomonocytic leukemia cells (WEHI-3B-Y1) to purified recombinant human hemopoietic factors in serum-free culture].
    Kajigaya Y; Sasaki H; Ikuta K; Matsuyama S
    Nihon Ketsueki Gakkai Zasshi; 1989 Aug; 52(5):835-41. PubMed ID: 2480048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line.
    Rahman HS; Rasedee A; Abdul AB; Zeenathul NA; Othman HH; Yeap SK; How CW; Hafiza WA
    Int J Nanomedicine; 2014; 9():527-38. PubMed ID: 24549090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo.
    He Q; Na X
    Leuk Res; 2001 Jun; 25(6):455-61. PubMed ID: 11337017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different inhibiting effect of cholera toxin on two leukemia cell lines does not correlate with their toxin binding capacity.
    Giuliani A; Calappi E; Mineo E; Neri MG; Gallina A; Pessina A
    Mol Cell Biochem; 1995 Nov; 152(2):103-12. PubMed ID: 8751156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and functional characterization of mature progeny purified from a myelomonocytic leukemia cell line.
    Cooper PC; Metcalf D; Burgess AW
    Leuk Res; 1982; 6(3):313-27. PubMed ID: 6956783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured Self-Assembling Peptides as a Defined Extracellular Matrix for Long-Term Functional Maintenance of Primary Hepatocytes in a Bioartificial Liver Modular Device [Retraction].
    Int J Nanomedicine; 2022; 17():3075-3076. PubMed ID: 35855747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.